Mineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney disease

被引：2
|
作者：
Ritz, E. [1 ]
Pitt, B. [2 ]
机构：
[1] Heidelberg Univ, Nierenzentrum, Heidelberg, Germany
[2] Univ Michigan, Med Sch, Internal Med & Cardiovasc Dis, Ann Arbor, MI 48109 USA
来源：
CLINICAL KIDNEY JOURNAL | 2013年 / 6卷 / 05期
关键词：
aldosterone blockade; chronic kidney disease; hyperkalaemia; potassium binder;
D O I：
10.1093/ckj/sft084
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Hyperkalaemia continues to be a major hazard of mineralocorticoid receptor blockade in an effort to retard the progression of chronic kidney disease (CKD). In cardiac patients on mineralocorticoid receptor blockade, RLY-5016 which captures K+ in the colon has been effective in reducing the risk of hyperkalaemia. This compound might be useful in CKD as well.
引用
收藏
页码：464 / 468
页数：5
相关论文
共 50 条
  • [31] Finerenone: a new mineralocorticoid receptor antagonist to beat chronic kidney disease
    Raj, Rajesh
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2022, 31 (03): : 265 - 271
  • [32] MINERALOCORTICOID RECEPTOR BLOCKADE IN CHILDREN WITH CHRONIC ALLOGRAFT INJURY
    Medeiros, Mara
    Velasquez-Jones, Luis
    Maria Hernandez, Ana
    Valverde, Saul
    Fuentes, Yolanda
    Barrera-Chimal, Johnatan
    Perez-Villalba, Rosalba
    Bobadilla-Sandoval, Norma
    [J]. PEDIATRIC TRANSPLANTATION, 2013, 17 : 71 - 71
  • [33] Mineralocorticoid antagonists in chronic kidney disease
    Al Dhaybi, Omar
    Bakris, George
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2017, 26 (01): : 50 - 55
  • [34] MINERALOCORTICOID RECEPTOR BLOCKADE IN CHRONIC HEART-FAILURE
    STRUTHERS, AD
    [J]. JOURNAL OF HUMAN HYPERTENSION, 1995, 9 (06) : 443 - 446
  • [35] Potassium binders for chronic hyperkalaemia in people with chronic kidney disease
    Natale, Patrizia
    Palmer, Suetonia C.
    Ruospo, Marinella
    Saglimbene, Valeria M.
    Strippoli, Giovanni F. M.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (06):
  • [36] Potential Role of Mineralocorticoid Receptor Antagonists in Nondiabetic Chronic Kidney Disease and Glomerular Disease
    Zachariah, Teena
    Radhakrishnan, Jai
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024,
  • [37] Efficacy and safety assessment of mineralocorticoid receptor antagonists in patients with chronic kidney disease
    Ding, Kaiyue
    Li, Zhuoyu
    Lu, Yingying
    Sun, Lin
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 115 : 114 - 127
  • [38] Effects of Chronic Kidney Disease on Nanomechanics of the Endothelial Glycocalyx Are Mediated by the Mineralocorticoid Receptor
    Fels, Benedikt
    Beyer, Arne
    Cazana-Perez, Violeta
    Giraldez, Teresa
    Navarro-Gonzalez, Juan F.
    de la Rosa, Diego Alvarez
    Schaefer, Franz
    Bayazit, Aysun K.
    Obrycki, Lukasz
    Ranchin, Bruno
    Holle, Johannes
    Querfeld, Uwe
    Kusche-Vihrog, Kristina
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
  • [39] Mineralocorticoid receptor antagonism improves diastolic dysfunction in chronic kidney disease in mice
    Bonnard, Benjamin
    Pieronne-Deperrois, Marie
    Djerada, Zoubir
    Elmoghrabi, Soumaya
    Kolkhof, Peter
    Ouvrard-Pascaud, Antoine
    Mulder, Paul
    Jaisser, Frederic
    Messaoudi, Smail
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2018, 121 : 124 - 133
  • [40] Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease
    Akira Nishiyama
    [J]. Hypertension Research, 2019, 42 : 293 - 300
12345